🔴 Moleculin Biotech is trading 12.32% down with no clear catalyst identified

Moleculin Biotech is trading 12.32% down at $0.32, with no clear company-specific catalyst identified for October 16, 2026.

• The latest listed company release is dated October 7; no October 16 announcement appears on its press-release page.
• An October 16 report covers shareholder approval of reverse-split authority and an increase to the stock plan, both approved October 9. It does not establish these explain the decline.
• The biotech sector is higher, so sector performance does not account for the drop.